Beijing Scitop Bio-tech Balance Sheet Health
Financial Health criteria checks 6/6
Beijing Scitop Bio-tech has a total shareholder equity of CN¥1.8B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥1.9B and CN¥86.0M respectively. Beijing Scitop Bio-tech's EBIT is CN¥56.8M making its interest coverage ratio -1.9. It has cash and short-term investments of CN¥744.8M.
Key information
0%
Debt to equity ratio
CN¥0
Debt
| Interest coverage ratio | -1.9x |
| Cash | CN¥744.79m |
| Equity | CN¥1.76b |
| Total liabilities | CN¥86.01m |
| Total assets | CN¥1.85b |
Recent financial health updates
No updates
Recent updates
Beijing Scitop Bio-tech Co., Ltd.'s (SZSE:300858) Earnings Haven't Escaped The Attention Of Investors
Sep 27
Weak Statutory Earnings May Not Tell The Whole Story For Beijing Scitop Bio-tech (SZSE:300858)
Aug 27Beijing Scitop Bio-tech (SZSE:300858) Will Pay A Smaller Dividend Than Last Year
Jun 29Investor Optimism Abounds Beijing Scitop Bio-tech Co., Ltd. (SZSE:300858) But Growth Is Lacking
Apr 18Beijing Scitop Bio-tech (SZSE:300858) Is Reinvesting At Lower Rates Of Return
Mar 22Financial Position Analysis
Short Term Liabilities: 300858's short term assets (CN¥867.8M) exceed its short term liabilities (CN¥53.6M).
Long Term Liabilities: 300858's short term assets (CN¥867.8M) exceed its long term liabilities (CN¥32.4M).
Debt to Equity History and Analysis
Debt Level: 300858 is debt free.
Reducing Debt: 300858 has no debt compared to 5 years ago when its debt to equity ratio was 0.8%.
Debt Coverage: 300858 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 300858 has no debt, therefore coverage of interest payments is not a concern.